Exercise program to enhance fitness and quality of life for lymphoma survivors
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors: A Randomized Controlled Trial
This study is testing a special exercise program with mobile health technology to see if it can help young adults who survived lymphoma feel better and improve their fitness.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | McGill University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT05257785 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial aims to evaluate the effectiveness of a tailored exercise program utilizing mobile health technology to improve fitness and quality of life in young adults who are lymphoma survivors. The study addresses the common challenges faced by these individuals, such as fatigue and anxiety, which can hinder their ability to engage in regular physical activity. Participants will receive guidance from an exercise physiologist and use a fitness tracker to monitor their progress. The goal is to encourage adherence to exercise guidelines and ultimately enhance the overall well-being of lymphoma survivors.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-39 who have been newly diagnosed with lymphoma and are cleared for vigorous exercise by their hematologist.
Not a fit: Patients who have contraindications to vigorous exercise or are unwilling to use a fitness tracker may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the physical fitness and quality of life for lymphoma survivors.
How similar studies have performed: Other studies have shown positive outcomes with exercise interventions for cancer survivors, indicating that this approach is promising and supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. newly diagnosed lymphoma patients who received an initial diagnosis at the age of age 18-39, 2. approved by their hematologist as having no contra-indications to vigorous exercise, 3. receiving or has received chemotherapy with curative intent within the past 6 months, 4. own a cellular phone that is able to download the Fitbit app and to complete the study questionnaires online in either French or English, and 5. has an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom). Exclusion Criteria: 1. The patient has contra-indications to vigorous exercise, 2. the patient doesn't want to wear a fitness tracker due to various concerns (as no Fitbit data could be collected).
Where this trial is running
Montreal, Quebec
- Jewish General Hospital — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Study coordinator: Christine Maheu, Ph.D.
- Email: christine.maheu@mcgill.ca
- Phone: 514-616-5954
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.